Figure 1From: Genomic and proteomic approaches for studying human cancer: Prospects for true patient-tailored therapyProfiling the disease signature for application to individualisation of therapy. From: Liotta, LA. et al. (2001), JAMA Vol. 286, p. 18. Used with permission.Back to article page